Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR-46.6%
5Y CAGR-29.1%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-46.6%/yr
Annual compound
5Y CAGR
-29.1%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 3.64% |
| 2024 | -31.80% |
| 2023 | 5.50% |
| 2022 | 23.90% |
| 2021 | -35.49% |
| 2020 | 20.36% |
| 2019 | -22.92% |
| 2018 | -7.43% |
| 2017 | -1111.83% |
| 2016 | 129.50% |